Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objectives</h3><p>Herpes simplex virus-1 (HSV-1) is one of the most prevalent viruses in human being worldwide and due to limited therapies mainly with acyclovir (ACV) and analogues and emergence of ACV resistant strains, the search for new drugs with different modes of action and low toxicity is required for public health. The aim of this study was to describe anti-HSV-1 effect and mechanism of flavonoid compound, dihydromyricetin (DHM).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>HSV-1 inhibitory effect of DHM was evaluated by measurement of plague formation and generation of progeny virus, and expression of HSV-1-related genes on Vero cells. The molecular mechanism of DHM anti-viral activity on HSV-1 was explored by real-time quantitative PCR (RT-qPCR) and ELISA assay.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>DHM presented significant inhibitory effect on HSV-1 plague formation and generation of progeny virus, with EC50 value (50% effective concentration) of 12.56 μM on Vero cells. Furthermore, the expression of HSV-1 immediate-early genes (ICP4, ICP22 and ICP27), early genes (ICP8 and UL42) and late genes (gB, VP1/2) were decreased by DHM at concentrations of 16 and 32 μM. The present study found that DHM specifically suppressed the mRNA levels of toll like receptor 9 (TLR9), leading the inflammatory transcriptional factor NF-κB inhibition, and the TNF-α decrease.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>These findings indicate that effective inhibitory activity of DHM performs were achieved by suppressing TNF-α production in a TLR9-dependent inflammatory response manner. Although further studies are needed to better characterize DHM activity in vivo, the results suggest this extract as a promising new anti-HSV-1 agent.</p>

Houttuynoids A-E, anti-herpes simplex virus active flavonoids with novel skeletons from Houttuynia cordata.

Houttuynoid M, an Anti-HSV Active Houttuynoid from Houttuynia Cordata Featuring a Bis-houttuynin Chain Tethered to a Flavonoid Core.

Anti HSV-1 Flavonoid Derivatives Tethered with Houttuynin from Houttuynia Cordata

Anti-herpes Simplex Virus Type 1 Activity of Houttuynoid A, a Flavonoid from Houttuynia Cordata Thunb.

Three new bisflavonols from the seeds of Hovenia dulcis Thunb. and their anti-RSV activities.

Houttuynia cordata Targets the Beginning Stage of Herpes Simplex Virus Infection

Alkaloids and amides from Houttuynia cordata

Total Synthesis of the Flavonoid Natural Product Houttuynoid A

Anti-Complementary Components Of Helicteres Angustifolia

Antiviral Clerodane Diterpenoids from Dodonaea Viscosa

New Glycosides from the Twigs and Leaves of Rhododendron Latoucheae.

Anti-complementary constituents of Houttuynia cordata and their targets in complement activation cascade.

Five New Phenolic Glycosides from Hedyotis Scandens

Two Pairs of New Diastereoisomeric Flavonolignans from the Seeds of Hovenia Acerba

Novel Tetrahydrofuran Derivatives from Trigonostemon Howii with Their Potential Anti-Hiv-1 Activities.

Hovendulcisic Acid A-D: Four Novel Ceanothane-Type Triterpenoids from Hovenia Dulcis Stems with Anticancer Properties

Anti-HSV-1 effect of dihydromyricetin from Ampelopsis grossedentata via the TLR9-dependent anti-inflammatory pathway

Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol

Activity-guided isolation and identification of antiherpesvirus and antineuroinflammatory active terpenoids from Artemisia vulgaris L. based on the LC-MS/MS molecular network

Antiviral Flavonoids from the Root Bark of Morus Alba L.

Nodulisporiviridins A-H, Bioactive Viridins from Nodulisporium Sp.